AF
RVNC

Atala Financial’s Revance Therapeutics, Inc. RVNC Stock Holding History

Atala Financial’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-145
Closed -$441 – 481
2024
Q4 		$441 Buy
+145
New +$441 ﹤0.01% 463